Integrated EHR: The Final Frontier


By BIO-IT World

Strategic Insights


Integrated EHR: The Final Frontier
Harmonizing various standards for electronic health records will have far-reaching effects on bioinformatics.

BY AMNON SHABO

Special Issue
·Strategic Insights:
Health Informatics
·Targeted Medicine via Molecular Diagnostics
·Making Information-Based Medicine Work
·Integrated EHR: The Final Frontier
·Finding a Pathway for EMR and EDC Integration
'Medical record" commonly refers to the legally attested data in electronic clinical documents that are maintained by a healthcare provider. Typically, the provider uses its own medical archiving system in some proprietary format, which creates two challenges:

· Sharing and exchanging medical records between providers is made difficult because of different formats.

· Medical professionals lack a "longitudinal view" of patients' medical histories because information is maintained in independent silos.

The result: Patients can be placed at risk because medical professionals may have to rely on poor record-keeping or incomplete information when diagnosing ailments or prescribing treatments.

Attempts to address these challenges have led the medical industry to unite in an effort to create an electronic health record (EHR) standard — real-time, paperless files that provide a comprehensive patient history, including medications dispensed, diagnostic test results, medical images, and recent vital signs. EHRs offer three critical advantages over traditional medical records:

· A longitudinal view, letting medical professionals gain a complete picture of a patient's medical history

· Cross-organizational access, enabling different doctor offices, hospitals, laboratories,and other medical institutions to share information equally

· Patient data not necessarily logged during official medical treatments, such as self-documentation and personal genome information

Consequently, in many ways EHRs represent the final frontier for healthcare informatics. Much work has to be done, though, before the life sciences industry can realize the exciting new possibilities for standardized EHRs.

Partly because of competing models, standards-development organizations haven't yet produced acceptable specifications for EHRs. Health Level Seven (HL7), the most dominant healthcare standards organization in the United States, has created a specification for a clinical document format called Clinical Document Architecture (CDA). A collection of patient CDA documents could serve as a good basis for EHRs, but a problem is the redundancy and lack of coherency that would be prevalent in such an aggregation of records.

In April 2003, several U.S. agencies, including the Centers for Medicare & Medicaid Services, the Veterans Health Administration, and the Agency for Healthcare Research and Quality, sought to further this initiative by asking HL7 to produce an "EHR functional model and standard" aimed at improving patient care. In response, a newly formed body, the HL7 EHR Special Interest Group (SIG), has begun a project to harmonize a variety of EHR approaches and forge a functional model that will achieve broad industry acceptance.


Common Building Blocks for Bioinformatics
On a parallel track, standardization efforts are well under way in the fields of medical informatics and bioinformatics. The Clinical Data Interchange Standards Consortium (CDISC), for example, has been forging standards to describe all data involved in clinical trials. Recently, CDISC activists established an HL7 technical committee that is attempting to express CDISC standards in HL7 "language," with the aim of eventually creating an American National Standards Institute (ANSI) standard.

Furthermore, members of HL7 have initiated a new HL7 SIG to define all usages of genomic data in healthcare practice. Bioinformatics markup formats, such as MAGE-ML for gene expression and BSML for biological sequencing, are being utilized, similar to the way controlled medical vocabularies are referenced.

How do these bioinformatics-oriented efforts relate to the EHR standardization effort? The answer lies in a recent "methodology shift" that major standards-development organizations are adopting. HL7, for example, has produced a number of ANSI standards for healthcare messaging, but these standards have lacked a common language, and their development methodology has been inconsistent.

The new Version 3, however, represents a quantum leap with the emergence of a central Reference Information Model (RIM) that consists of common building blocks from which each committee can derive its specifications. These include core classes, such as acts, entities, and associations, all organized in a coherent framework called the Unified Service Action Model.

The result: a common language on which all HL7 standards may be based. Different health standards-development organizations will eventually agree on a common Health RIM, and this agreement will boost the usability of all specifications derived from such an RIM, enabling the desired goal of semantic interoperability.

This would represent one more step toward reaching the final frontier for healthcare informatics — a resource that could one day save time, money, and perhaps lives by avoiding medical errors with a virtual medical chart that would give any healthcare provider in any location the ability to instantly review a comprehensive, up-to-date patient history. *



Amnon Shabo is a research staff member at the IBM Research Lab in Haifa, Israel. He may be reached at shabo@il.ibm.com.





Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Waters white paper image
Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


sas whitepaper92
Managed Innovation, Assured Compliance
Sponsored by SAS
Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process


BlueArc white paper image
Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health  (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required.  More job detail is found at:  http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at seniorre@od.nih.gov.  Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008.  DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here 

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.